Statistical Analysis
Providing Insight into Data
HEOR analysis of the RCT data
1
We analyze both RCT data and real-world observational data, including surveys, claims databases and registries.
​
Our goal is to fully exploit their HEOR potential, and explore additional treatment effects.
​
We analyze Phase 2 and Phase 3 FDA-approved STDN ADAM datasets in SAS.
What for?
Efficient use of existing resources, resulting in deep insight in own clinical data (40-80 new data tables).
Allows for data exploration and finding of additional treatment effects
Psychometric performance of PRO or clinical endpoints
2
What for?
- 
To better understand the items and the total score of a PRO 
- 
To identify the most responsive items 
- 
To explore treatment effects on items 
- 
To validate the PRO in the study population 
​​​
Determining the MCID of a PRO or clinical endpoint
3
What for?
- 
To calculate the minimum amount of change in a (primary or secondary endpoint) PRO that represents a true change in the patient’s health condition. 
- 
Results are used to interpret study results, recalculate treatment effect on a secondary endpoint, and calculate the proportion of responders. 
Determining the minimal important difference of EQ-5D-5L utility values in CIDP patients using data from a large clinical trial. To be submitted
Estimating the Minimal Clinically Important Difference for the Myasthenia Gravis Quality of Life revised scale (MG-QOL15r). Submitted Qual Life Res
Mixed methods and textual analysis
4
What for?
We analyze qualitative data in NVIVO, to understand what patients find important:
- 
Which symptoms are most or least burdensome? 
- 
Are there symptoms not included in the clinical study programme? 
- 
Which symptoms would they choose to alleviate first? 
- 
What are the most experienced symptoms? 
It is important to integrate the patient's voice in the selection of endpoints.
Other statistical analysis techniques
We use SAS/STATA, R, Python or VBA, and a variety of analysis techniques including, but not limited to:​​
- 
Survival analysis 
- 
Longitudinal analysis, with missing data methods 
- 
Resource utilization and cost analysis 
- 
Time-series analysis 
- 
Multilevel analysis 
- 
Analysis of discrete choice experiments 
- 
Factor analysis 
- 
Clustering analysis 
- 
Propensity score adjustment for non-randomization 
